BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15352029)

  • 1. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells.
    Maehara S; Tanaka S; Shimada M; Shirabe K; Saito Y; Takahashi K; Maehara Y
    Int J Cancer; 2004 Nov; 112(2):184-9. PubMed ID: 15352029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells.
    Suenaga S; Kuramitsu Y; Wang Y; Baron B; Kitagawa T; Akada J; Tokuda K; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2013 Nov; 33(11):4821-6. PubMed ID: 24222118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine.
    Mori-Iwamoto S; Kuramitsu Y; Ryozawa S; Mikuria K; Fujimoto M; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Int J Oncol; 2007 Dec; 31(6):1345-50. PubMed ID: 17982661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells.
    Kuramitsu Y; Suenaga S; Wang Y; Tokuda K; Kitagawa T; Tanaka T; Akada J; Maehara S; Maehara Y; Nakamura K
    Anticancer Res; 2013 Aug; 33(8):3133-6. PubMed ID: 23898070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer: increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance.
    Ina S; Hirono S; Noda T; Yamaue H
    Pancreas; 2010 May; 39(4):473-85. PubMed ID: 19959962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis.
    Nakai Y; Otsuka M; Hoshida Y; Tada M; Komatsu Y; Kawabe T; Omata M
    Oncol Rep; 2005 Nov; 14(5):1263-7. PubMed ID: 16211294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine.
    Suenaga S; Kuramitsu Y; Kaino S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Anticancer Res; 2014 Jan; 34(1):141-6. PubMed ID: 24403454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.
    Kuramitsu Y; Wang Y; Kitagawa T; Tokuda K; Akada J; Tokunaga M; Nakamura K
    Anticancer Res; 2015 Jul; 35(7):3861-5. PubMed ID: 26124331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer.
    Baron B; Fujioka T; Kitagawa T; Maehara S; Maehara Y; Nakamura K; Kuramitsu Y
    Cancer Genomics Proteomics; 2015; 12(2):83-7. PubMed ID: 25770192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine.
    Taba K; Kuramitsu Y; Ryozawa S; Yoshida K; Tanaka T; Mori-Iwamoto S; Maehara S; Maehara Y; Sakaida I; Nakamura K
    Chemotherapy; 2011; 57(1):12-6. PubMed ID: 21124027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine.
    Mori-Iwamoto S; Taba K; Kuramitsu Y; Ryozawa S; Tanaka T; Maehara S; Maehara Y; Okita K; Nakamura K; Sakaida I
    Pancreas; 2009 Mar; 38(2):224-6. PubMed ID: 19238023
    [No Abstract]   [Full Text] [Related]  

  • 12. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells.
    Tokunaga M; Baron B; Kitagawa T; Tokuda K; Kuramitsu Y
    Anticancer Res; 2015 Nov; 35(11):6063-7. PubMed ID: 26504030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
    Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
    Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer.
    Akada M; Crnogorac-Jurcevic T; Lattimore S; Mahon P; Lopes R; Sunamura M; Matsuno S; Lemoine NR
    Clin Cancer Res; 2005 Apr; 11(8):3094-101. PubMed ID: 15837765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles.
    Chen Z; Zhao L; Shi K; Chen B
    Clin Lab; 2018 May; 64(5):749-757. PubMed ID: 29739052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH; Zhang ZY; Che CL; Mei YF; Shi YZ
    Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
    Zhang Z; Duan Q; Zhao H; Liu T; Wu H; Shen Q; Wang C; Yin T
    Cancer Lett; 2016 Nov; 382(1):53-63. PubMed ID: 27576197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the proteasome inhibitor bortezomib on gene expression profiles of pancreatic cancer cells.
    Tang ZY; Wu YL; Gao SL; Shen HW
    J Surg Res; 2008 Mar; 145(1):111-23. PubMed ID: 17714734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.
    Nakano Y; Tanno S; Koizumi K; Nishikawa T; Nakamura K; Minoguchi M; Izawa T; Mizukami Y; Okumura T; Kohgo Y
    Br J Cancer; 2007 Feb; 96(3):457-63. PubMed ID: 17224927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.